Euro Stars 2023
Our Fixed Income team was recently awarded a solid ranking in the Euro Stars 2023 guide, CityWire's annual list of Europe's top-performing fund managers.
- Top ranking, Fixed Income, Norwegian Bonds
- #141 overall across all asset classes
Methodology for Euro Stars ranking:
The Euro Stars guide is based on a fund manager’s track record over the last three years. This performance is calculated using total returns, priced at bid to bid, with income reinvested at the ex-dividend date. The managers are then ranked using the Citywire Manager Ratio, which is a modified version of the Information Ratio that factors in all the eligible funds across all asset classes and sectors an individual runs over that time period.
The data used covers the three years to 28 February 2023.
In order to be eligible, a manager must have been active for a minimum of three years within the prescribed timeframe and be active at the end of that period. The manager must also be currently active in managing funds registered for sale in at least three of the following countries: UK, Ireland, Luxembourg, Austria, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Belgium, Denmark, Estonia, Finland, Latvia, Lithuania, Norway, Poland, Portugal, Cyprus, Gibraltar, Guernsey, Isle of Man, Jersey, Liechtenstein and Malta.
Once the eligibility criteria above are met, the top 250 managers ranked by Manager Ratio are awarded a Euro Stars rating.
This elite group are then arranged by the sectors in which they run funds, in order of their respective Manager Ratio, which is measured across all Euro Stars funds managed (find the full tables at the back). Each manager profile includes the total assets under management across all funds they run in that respective sector.
Latest news
Arctic Asset Management - Roche appreciates 5.8% on promising oral anti-obesity data
NEWS. Roche finished Wednesday 5.8% up, corresponding to more than USD 16 billion in market cap, after disclosing Phase 1 data from CT-996 in obese patients, showing 7.3% weight loss (6.1% placebo-adjusted) after four weeks of treatment. Importantly, there were no treatment discontinuations, and according to the company the compound’s side effect profile is in-line with other similar molecules.
Arctic Asset Management - Markedskommentar Juni 2024
Aksjemarkedet hadde en positiv utvikling i mai, hvor Oslo Børs ledet an med en oppgang på 5,2% hjulpet av en bred oppgang i råvarepriser og fortsatt god fart i shipping. Globalt steg verdensindeksen målt ved MSCI World Index (NOK) med 3,9% og det amerikanske aksjemarkedet steg 4,8% (S&P 500 USD).
Arctic Asset Management - Arctic Midt i Måneden
Arctic Global Select - Det nye fondet "alle" snakker om
Albert Collett har fått besøk i studio av forvalter, Tone Varmann, som forteller om det nye fondet «Arctic Global Select». Et globalt og aktivt forvaltet aksjefond i samarbeid med “glokale” spesialister.
Hør hvordan Tone bygger et globalt forvalterteam, med sektorspesialister i de mest disruptive delene av markedet som komplementerer hverandre gjennom skiftende markedsforhold. – og hvem det nye aksjefondet, Arctic Global Select, passer for.
Arctic Asset Management - Markedskommentar Mai 2024
Aksjemarkedet hadde en positiv utvikling i mai, hvor Oslo Børs ledet an med en oppgang på 5,2% hjulpet av en bred oppgang i råvarepriser og fortsatt god fart i shipping. Globalt steg verdensindeksen målt ved MSCI World Index (NOK) med 3,9% og det amerikanske aksjemarkedet steg 4,8% (S&P 500 USD).
Arctic Asset Management - Insmed announced breakthrough results from landmark respiratory study
Shares of Arctic Aurora LifeScience and Arctic Aurora Biotech Select holding Insmed appreciated 118% on positive Phase 3 results in bronchiectasis
Arctic Asset Management - Biotech hitting the news
This morning, Ulrica Slåne Bjerke, portfolio manager and CIO for our healthcare funds Arctic Aurora LifeScience and Biotech Select, was invited to Dagens Industri’s TV Börsmorgon. She commented on topics currently in focus regarding the sector, obesity stocks Novo and Lilly, falling interest rates positive for biotech, Novavax share price soaring as well as some Swedish med tech companies having an uphill day.